Fc receptor but not complement binding is important in antibody protection against HIV. - Wikidata - awgldk - TriplyDB

Fc receptor but not complement binding is important in antibody protection against HIV.

Fc receptor but not complement binding is important in antibody protection against HIV.

http://www.wikidata.org/entity/Q46545827

about

Increasing the potency and breadth of an HIV antibody by using structure-based rational design The aftermath of the Merck's HIV vaccine trial Structural basis of potent Zika–dengue virus antibody cross-neutralization Specificity, cross-reactivity and function of antibodies elicited by Zika virus infection Immune correlates of vaccine protection against HIV-1 acquisition Conformational Masking and Receptor-Dependent Unmasking of Highly Conserved Env Epitopes Recognized by Non-Neutralizing Antibodies That Mediate Potent ADCC against HIV-1 Fc receptors and their influence on efficacy of therapeutic antibodies for treatment of viral diseases The role of Fc-FcγR interactions in IgG-mediated microbial neutralization The evolution within us Antibody responses to envelope glycoproteins in HIV-1 infection The Antibody Response against HIV-1 Host-pathogen interaction in HIV infection Origin of the transmitted virus in HIV infection: infected cells versus cell-free virus A global approach to HIV-1 vaccine development HIV vaccine development: strategies for preclinical and clinical investigation AAV-Delivered Antibody Mediates Significant Protective Effects against SIVmac239 Challenge in the Absence of Neutralizing Activity Human Non-neutralizing HIV-1 Envelope Monoclonal Antibodies Limit the Number of Founder Viruses during SHIV Mucosal Infection in Rhesus Macaques Antigenic properties of the human immunodeficiency virus envelope glycoprotein gp120 on virions bound to target cells Elimination of HIV-1-infected cells by broadly neutralizing antibodies Impaired antibody response causes persistence of prototypic T cell-contained virus Biocompatible anionic polymeric microspheres as priming delivery system for effetive HIV/AIDS Tat-based vaccines ADCC develops over time during persistent infection with live-attenuated SIV and is associated with complete protection against SIV(mac)251 challenge The structural immunology of antibody protection against West Nile virus Sang Froid in a time of trouble: is a vaccine against HIV possible?Antibodies against viruses: passive and active immunization Complement Protein C1q Reduces the Stoichiometric Threshold for Antibody-Mediated Neutralization of West Nile Virus Structural Definition of an Antibody-Dependent Cellular Cytotoxicity Response Implicated in Reduced Risk for HIV-1 Infection Deconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and Immunity A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins Diverse specificity and effector function among human antibodies to HIV-1 envelope glycoprotein epitopes exposed by CD4 binding Structural basis for HIV-1 gp120 recognition by a germ-line version of a broadly neutralizing antibody Structure of a Classical Broadly Neutralizing Stem Antibody in Complex with a Pandemic H2 Influenza Virus Hemagglutinin Neutralizing antibodies to HIV-1 envelope protect more effectively in vivo than those to the CD4 receptor Patterns of HIV/SIV Prevention and Control by Passive Antibody Immunization Cell-targeting antibodies in immunity to Ebola High-throughput quantitative analysis of HIV-1 and SIV-specific ADCC-mediating antibody responses The Neonatal Fc receptor (FcRn) enhances human immunodeficiency virus type 1 (HIV-1) transcytosis across epithelial cells Measurements of immune responses for establishing correlates of vaccine protection against HIV A novel class of anti-HIV agents with multiple copies of enfuvirtide enhances inhibition of viral replication and cellular transmission in vitro Systems serology for evaluation of HIV vaccine trials.

P2860

Q24631510-11243D00-60AB-44D6-A3AE-0C4E87373A9E Q24654458-AB7A94AB-42C2-4F5B-8D32-E48895B6A76B Q24740325-0FFEF227-0C50-4F27-A58D-B60611665953 Q26252507-A4F1F666-D20A-471A-A8B3-965DA0A8544D Q26778573-56F228E7-A2C8-4BD2-B75B-C313F3063E76 Q26782237-BBBE87E9-F33E-413B-A4E0-CEC1E5331F2B Q26783175-8EF2B3BF-6F21-429B-A5D0-B030441903A1 Q26797466-9CBB0401-F279-4DA2-AC77-39347F9B00A1 Q26801603-0FAB5E6D-BAD1-44B4-B2B9-106BE28EEB0E Q26991572-FD5551FF-FBC1-40F9-8334-670964E00077 Q27000889-4E742064-E0EA-448E-804D-639274A8DC01 Q27009024-F5103336-F4EF-4E44-A79D-BD498E138721 Q27021279-3A3A2779-16C6-4EC4-902B-2C741397BEDC Q27024614-D31E24EF-C280-401A-9828-D9604D7FD450 Q27025917-32D6CF34-36C3-4DD1-9132-C205808003F3 Q27318266-0EDE22F6-3AE7-4B15-B8AB-C12379B8C24D Q27318508-92A3CADD-B70B-4F96-ADD5-A111E6DDE7E1 Q27320687-949593CB-4013-47C3-BA0F-D96992C440EC Q27329126-3CEDEECD-BE5C-460A-B69C-682201B43C2A Q27331309-04533C13-86C3-48BD-A0FB-6C4F9B291043 Q27333734-77A27B08-5CA1-4564-8A5D-466FD16A1CB4 Q27342615-65828B61-46B3-4B96-B90E-A9478FCFCBC5 Q27487955-0129DFA4-3F63-4F2F-8922-D653C8D34B9D Q27487961-32E775F8-601D-4ED1-BB84-109D5D460EB2 Q27489392-5CE17EA7-11BB-47C3-86E7-0C6084008AF8 Q27490423-E26319D7-3E46-4D73-8149-A6E2997E433C Q27640572-D7181C97-64FB-4F38-B2DA-3D2D69CDBDB8 Q27654848-79AEC8B8-AAE1-4496-9B79-C29100D92067 Q27671165-7EA5FD17-B06C-4342-A012-093C6C92169B Q27675486-48E83228-3BA0-483E-8620-41B66C191F48 Q27677011-A750B60F-460E-4FA0-BFB8-A7D18ED527BC Q27677191-EC99669A-12AB-44B9-BA4F-273E379454C8 Q27684529-F3EE1143-65B5-41D0-812B-B9BBA515C735 Q28068018-CE63DB66-8794-42BB-BDD0-6E67898A30C3 Q28068972-D76EE9FB-D450-4500-9ECF-5B7FDC2B92A7 Q28242631-437A0F3F-DB2C-4B8E-B43D-2BA8D514F665 Q28302792-BBDC0CA8-970E-4216-B399-8C4BDD954CB6 Q28728189-A6A2AA81-07AC-408A-8E32-4F920FD50ED1 Q28728917-8FBDC6FC-B490-4499-8E56-540BD00900B8 Q30238729-6536C9FB-0301-4FA5-AFA7-F13DBB944A1F

P2860

Fc receptor but not complement binding is important in antibody protection against HIV.

http://www.wikidata.org/entity/Q46545827

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh-hant

name

Fc receptor but not complement binding is important in antibody protection against HIV.

@en

Fc receptor but not complement binding is important in antibody protection against HIV.

@nl

type

label

Fc receptor but not complement binding is important in antibody protection against HIV.

@en

Fc receptor but not complement binding is important in antibody protection against HIV.

@nl

prefLabel

Fc receptor but not complement binding is important in antibody protection against HIV.

@en

Fc receptor but not complement binding is important in antibody protection against HIV.

@nl

P1433

Q46545827-4F415375-1726-45DD-9CA3-761BB55759D7

P1476

Q46545827-84985D40-4563-4BCA-9BA5-BC1BA594B29E

P2093

Q46545827-15332091-DD22-4F5F-B47F-C89524A69B0B

Q46545827-3ACEB94D-FB16-45FE-A45B-0876B62E508C

Q46545827-51FB634F-08F7-4099-893C-E7466E2D57B8

Q46545827-5CFD2C3E-1269-4CE5-965E-6D0409429AC2

Q46545827-7AB198FB-453A-438C-A959-46617DA0776C

Q46545827-890AB0F5-3635-435C-8EB0-0AC8768DA9CE

Q46545827-C3855099-3DBC-47F8-94C5-B34C4D67E5EC

Q46545827-D3719C4E-F7B0-4C3F-8A55-A9BCA8644136

Q46545827-E6C6622F-7061-4878-98CE-A58CEE008EF8

Q46545827-E7BADAAA-5EA3-490D-9633-06302C0C7F1E

P2888

Q46545827-9991FBB3-2C2D-44FD-B1FF-143E8902A54E

P304

Q46545827-4E369764-B8E5-496F-BE73-AC21838AF0F2

P31

Q46545827-79F1E20B-26C7-430E-8047-B45C5EA771C5

P356

Q46545827-1D5A3F89-8F3F-4903-9461-F364AB310443

P407

Q46545827-3F2FC0EC-40FE-4131-8925-AEF59B1CF7F9

P433

Q46545827-86D8EF3F-B219-444C-A23A-A3C8254E243F

P478

Q46545827-3C5FF9D0-E3CB-4952-BEC6-A7F5642D792F

P50

Q46545827-DB260496-F105-4982-9CA5-40B33668B0A5

P577

Q46545827-00364730-73CA-4CDA-8BF2-8592A00F35A6

P5875

Q46545827-A0F11BC4-56CE-4994-ACCE-53CC40DD81C9

P6179

Q46545827-6C02660B-E6A8-42E2-9E5F-2BDEA857E5FC

P698

Q46545827-1E8B77AF-5EDD-4B59-B7BD-0B4AC73329E7

P921

Q46545827-CCA95347-D0E5-4AA4-B5AB-FCAAE126CAAF

P356

P1433

P1476

Fc receptor but not complement binding is important in antibody protection against HIV.

@en

P2093

Ann J Hessell

http://www.w3.org/2001/XMLSchema#string

Carin E G Havenith

http://www.w3.org/2001/XMLSchema#string

Caroline M S Lanigan

http://www.w3.org/2001/XMLSchema#string

Dennis R Burton

http://www.w3.org/2001/XMLSchema#string

Donald N Forthal

http://www.w3.org/2001/XMLSchema#string

Frank J Beurskens

http://www.w3.org/2001/XMLSchema#string

Gary Landucci

http://www.w3.org/2001/XMLSchema#string

Joost M Bakker

http://www.w3.org/2001/XMLSchema#string

Lars Hangartner

http://www.w3.org/2001/XMLSchema#string

Meredith Hunter

http://www.w3.org/2001/XMLSchema#string

P2888

P304

101-104

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NATURE06106

http://www.w3.org/2001/XMLSchema#string

P407

P433

7158

http://www.w3.org/2001/XMLSchema#string

P478

449

http://www.w3.org/2001/XMLSchema#string

P50

Paul Whi Parren

P577

2007-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6035785

http://www.w3.org/2001/XMLSchema#string

P6179

1003318475

http://www.w3.org/2001/XMLSchema#string

P698

17805298

http://www.w3.org/2001/XMLSchema#string

P921